beta
AKTX
Akari Therapeutics Plc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Akari Therapeutics PLC is a biopharmaceutical company in clinical stage. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system and the eicosanoid system.
Market Cap: 48.7 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.akaritx.com
Shares Outstanding: 15.3 Million
Float: 13.9 Million
Dividend: 0.0 (0.0%)
Beta: -8.834261
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 597 Thousand
Ethical Flags
Longest drawdown: 1930 trading days
From: 2014-01-15 To: 2019-10-11
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2015-09-17 | 10.0 | 1.0 | 10.0 |